Choosing a blood-glucose-lowering agent after metformin.
Diabetes Centre, VU University Medical Centre, 1081 HV Amsterdam, The Netherlands. m.diamant@vumc.nl
Michaela
M
Diamant
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D011719:Pyrazines; D014230:Triazoles; D000069036:Insulin Glargine; D008687:Metformin; D000068900:Sitagliptin Phosphate